nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A comprehensive review of official discount rates in guidelines of health economic evaluations over time: the trends and roots
|
Khorasani, Elahe |
|
|
|
9 |
p. 1577-1590 |
artikel |
2 |
A direct method for the identification of patterns of care using administrative databases: the case of breast cancer
|
Busco, Susanna |
|
|
|
9 |
p. 1477-1485 |
artikel |
3 |
A European multinational cost-effectiveness analysis of empagliflozin in heart failure with reduced ejection fraction
|
Tafazzoli, Ali |
|
|
|
9 |
p. 1441-1454 |
artikel |
4 |
A methodological proposal to evaluate the cost of duration moral hazard in workplace accident insurance
|
Martín-Román, Ángel |
|
2017 |
|
9 |
p. 1181-1198 |
artikel |
5 |
Analysing coverage decision-making: opening Pandora’s box?
|
Fischer, Katharina Elisabeth |
|
2014 |
|
9 |
p. 899-906 |
artikel |
6 |
An examination of the relationships between service use and alternative measures of obesity among community-dwelling adults in Ireland
|
Doherty, Edel |
|
2014 |
|
9 |
p. 951-956 |
artikel |
7 |
Are costs derived from diagnosis-related groups suitable for use in economic evaluations? A comparison across nine European countries in the European Healthcare and Social Cost Database
|
Špacírová, Zuzana |
|
|
|
9 |
p. 1563-1575 |
artikel |
8 |
A review of economic evaluation models for cardiac resynchronization therapy with implantable cardioverter defibrillators in patients with heart failure
|
Tomini, F. |
|
2016 |
|
9 |
p. 1159-1172 |
artikel |
9 |
Brand switching or reduced consumption? A study of how cigarette taxes affect tobacco consumption
|
Chen, Chiang-Ming |
|
2013 |
|
9 |
p. 991-998 |
artikel |
10 |
Budget impact analysis of the use of oral and intravenous therapy regimens for the treatment of relapsed or refractory multiple myeloma in Germany
|
Basic, Edin |
|
|
|
9 |
p. 1351-1361 |
artikel |
11 |
Budget impact of parenteral iron treatment of iron deficiency: methodological issues raised by using real-life data
|
Brock, Elisabeth |
|
2013 |
|
9 |
p. 907-916 |
artikel |
12 |
Burden of disease in multiple sclerosis patients with spasticity in Germany: mobility improvement study (Move I)
|
Zettl, Uwe K. |
|
2013 |
|
9 |
p. 953-966 |
artikel |
13 |
Comparing the measurement properties of the ICECAP-A and ICECAP-O instruments in ages 50–70: a cross-sectional study on a representative sample of the Hungarian general population
|
Baji, Petra |
|
|
|
9 |
p. 1453-1466 |
artikel |
14 |
Comparison of the preference-based EQ-5D-5L and SF-6D in patients with end-stage renal disease (ESRD)
|
Yang, Fan |
|
2014 |
|
9 |
p. 1019-1026 |
artikel |
15 |
Correction to: Cost‑effectiveness analysis of stand‑alone or combined non‑invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study
|
Lorenzoni, Valentina |
|
|
|
9 |
p. 1451 |
artikel |
16 |
Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology
|
Lipman, Stefan A. |
|
|
|
9 |
p. 1613-1615 |
artikel |
17 |
Cost analysis and cost-benefit analysis of a medication review with follow-up service in aged polypharmacy patients
|
Malet-Larrea, Amaia |
|
2016 |
|
9 |
p. 1069-1078 |
artikel |
18 |
Cost and cost-effectiveness of four different SARS-CoV-2 active surveillance strategies: evidence from a randomised control trial in Germany
|
Nguyen, Hoa Thi |
|
|
|
9 |
p. 1545-1559 |
artikel |
19 |
Cost-effectiveness analysis of stand-alone or combined non-invasive imaging tests for the diagnosis of stable coronary artery disease: results from the EVINCI study
|
Lorenzoni, Valentina |
|
|
|
9 |
p. 1437-1449 |
artikel |
20 |
Cost-effectiveness of enhancing a Quit-and-Win smoking cessation program for college students
|
Popp, Jonah |
|
2018 |
|
9 |
p. 1319-1333 |
artikel |
21 |
Cost-effectiveness of linaclotide compared to antidepressants in the treatment of irritable bowel syndrome with constipation in Scotland
|
Fisher, Mark |
|
2016 |
|
9 |
p. 1091-1100 |
artikel |
22 |
Cost-effectiveness of ravulizumab compared with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria in the Netherlands
|
Quist, S. W. |
|
|
|
9 |
p. 1455-1472 |
artikel |
23 |
Cost-effectiveness of smoking cessation programs for hospitalized patients: a systematic review
|
Lee, Donghoon |
|
|
|
9 |
p. 1409-1424 |
artikel |
24 |
Cost effects of hospital mergers in Portugal
|
Azevedo, Helda |
|
2013 |
|
9 |
p. 999-1010 |
artikel |
25 |
Costs and benefits of interventions aimed at major infectious disease threats: lessons from the literature
|
Kellerborg, Klas |
|
|
|
9 |
p. 1329-1350 |
artikel |
26 |
Cost–utility analysis of an intervention designed to reduce the critical handling error of insufficient inspiratory effort
|
Forster, Rebecca |
|
2018 |
|
9 |
p. 1303-1318 |
artikel |
27 |
Cost-utility of ranolazine for the symptomatic treatment of patients with chronic angina pectoris in Spain
|
Hidalgo-Vega, Álvaro |
|
2013 |
|
9 |
p. 917-925 |
artikel |
28 |
Determinants of utilisation differences for cancer medicines in Belgium, Scotland and Sweden
|
Ferrario, Alessandra |
|
2016 |
|
9 |
p. 1095-1105 |
artikel |
29 |
Determinants of willingness to pay for health services: a systematic review of contingent valuation studies
|
Steigenberger, Caroline |
|
|
|
9 |
p. 1455-1482 |
artikel |
30 |
Diffusion of pharmaceuticals: cross-country evidence of anti-TNF drugs
|
Brekke, Kurt Richard |
|
2013 |
|
9 |
p. 937-951 |
artikel |
31 |
Does smoke cross the border? Cigarette tax avoidance in France
|
Ben Lakhdar, Christian |
|
2015 |
|
9 |
p. 1073-1089 |
artikel |
32 |
Does uptake of specialty care affect HRQoL development in COPD patients beneficially? A difference-in-difference analysis linking claims and survey data
|
Stöber, Alisa |
|
|
|
9 |
p. 1561-1573 |
artikel |
33 |
Do renewable energy and health expenditures improve load capacity factor in the USA and Japan? A new approach to environmental issues
|
Pata, Ugur Korkut |
|
|
|
9 |
p. 1427-1439 |
artikel |
34 |
Driving time drives the hospital choice: choice models for pelvic organ prolapse surgery in Italy
|
Ferrari, Amerigo |
|
|
|
9 |
p. 1575-1586 |
artikel |
35 |
Early start of anti-dementia medication is associated with lower health and social care costs in Alzheimer´s patients: a Finnish nationwide register study
|
Vesikansa, Aino |
|
|
|
9 |
p. 1421-1428 |
artikel |
36 |
Economic evaluation of personalized medicine: a call for real-world data
|
Terkola, Robert |
|
2017 |
|
9 |
p. 1065-1067 |
artikel |
37 |
Economic evaluation of Zepatier for the management of HCV in the Italian scenario
|
Rolli, F. R. |
|
2018 |
|
9 |
p. 1365-1374 |
artikel |
38 |
Effect of financial inclusion on out-of-pocket health expenditure: empirics from Ghana
|
Koomson, Isaac |
|
|
|
9 |
p. 1411-1425 |
artikel |
39 |
Effects of pay-for-performance for primary care physicians on diabetes outcomes in single-payer health systems: a systematic review
|
Gupta, Neeru |
|
|
|
9 |
p. 1303-1315 |
artikel |
40 |
Efficiency ratio and rocketing drug prices: old concerns and new possibilities
|
Capri, Stefano |
|
|
|
9 |
p. 1273-1277 |
artikel |
41 |
Efficient health research and improving Europeans’ health
|
Antoñanzas, Fernando |
|
2015 |
|
9 |
p. 913-915 |
artikel |
42 |
Endogenous risk-taking and physical appearance of sex workers
|
Egger, Peter H. |
|
2014 |
|
9 |
p. 941-949 |
artikel |
43 |
EQ-5D in skin conditions: an assessment of validity and responsiveness
|
Yang, Yaling |
|
2014 |
|
9 |
p. 927-939 |
artikel |
44 |
EQ-5D-5L Portuguese population norms
|
Ferreira, Pedro L. |
|
|
|
9 |
p. 1411-1420 |
artikel |
45 |
Equity in healthcare utilization in Canada’s publicly funded health system: 2000–2014
|
Hirello, Laura |
|
|
|
9 |
p. 1519-1533 |
artikel |
46 |
Examining unpriced risk heterogeneity in the Dutch health insurance market
|
Withagen-Koster, A. A. |
|
2018 |
|
9 |
p. 1351-1363 |
artikel |
47 |
Exploring the determinants of endocrinologist visits by patients with diabetes
|
Andrade, Luiz Flavio |
|
2016 |
|
9 |
p. 1173-1184 |
artikel |
48 |
Ex-post moral hazard in the health insurance market: empirical evidence from German data
|
Thönnes, Stefanie |
|
|
|
9 |
p. 1317-1333 |
artikel |
49 |
Funding orphan medicinal products beyond price: sustaining an ecosystem
|
de Sola-Morales, Oriol |
|
|
|
9 |
p. 1283-1286 |
artikel |
50 |
Gender-specific practice styles and ambulatory health care expenditures
|
Kaiser, Boris |
|
2016 |
|
9 |
p. 1157-1179 |
artikel |
51 |
General population normative data for the EQ-5D-3L in the five largest European economies
|
Janssen, Mathieu F. |
|
|
|
9 |
p. 1467-1475 |
artikel |
52 |
General practitioners’ income and activity: the impact of multi-professional group practice in France
|
Cassou, Matthieu |
|
|
|
9 |
p. 1295-1315 |
artikel |
53 |
Health burden and costs of obesity and overweight in Germany: an update
|
Lehnert, Thomas |
|
2014 |
|
9 |
p. 957-967 |
artikel |
54 |
Health care costs of borderline personality disorder and matched controls with major depressive disorder: a comparative study based on anonymized claims data
|
Bode, Katharina |
|
2016 |
|
9 |
p. 1125-1135 |
artikel |
55 |
Health inequality indices and exogenous risk factors: an illustration on Luxembourgish workers
|
Mussard, Stéphane |
|
2018 |
|
9 |
p. 1285-1301 |
artikel |
56 |
Health state utilities associated with attributes of treatments for hepatitis C
|
Matza, Louis S. |
|
2014 |
|
9 |
p. 1005-1018 |
artikel |
57 |
Health state utility values (QALY weights) for Huntington’s disease: an analysis of data from the European Huntington’s Disease Network (EHDN)
|
Hawton, Annie |
|
|
|
9 |
p. 1335-1347 |
artikel |
58 |
How French general practitioners respond to declining medical density: a study on prescription practices, with an insight into opioids use
|
Silhol, Julien |
|
|
|
9 |
p. 1391-1398 |
artikel |
59 |
HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies
|
Coyle, Doug |
|
|
|
9 |
p. 1421-1437 |
artikel |
60 |
Human papillomavirus in Italy: retrospective cohort analysis and preliminary vaccination effect from real-world data
|
Marcellusi, A. |
|
|
|
9 |
p. 1371-1379 |
artikel |
61 |
Identifying factors associated with high use of acute care in Canada: a population-based retrospective study
|
Zhang, Mengmeng |
|
|
|
9 |
p. 1505-1515 |
artikel |
62 |
Impact of increasing treatment rates on cost-effectiveness of subcutaneous immunotherapy (SCIT) in respiratory allergy: a decision analytic modelling approach
|
Richter, Ann-Kathrin |
|
2018 |
|
9 |
p. 1229-1242 |
artikel |
63 |
Improving risk equalization with constrained regression
|
Kleef, Richard C. van |
|
2016 |
|
9 |
p. 1137-1156 |
artikel |
64 |
Incentivizing research into the effectiveness of medical devices
|
Drummond, Michael |
|
2016 |
|
9 |
p. 1055-1058 |
artikel |
65 |
Long-term cost of breast cancer treatment to the United States Medicare Program by stage at diagnosis
|
Grady, Ian |
|
|
|
9 |
p. 1365-1370 |
artikel |
66 |
Looking into the black box of “Medical Innovation”: rising health expenditures by illness type
|
Breyer, Friedrich |
|
|
|
9 |
p. 1601-1612 |
artikel |
67 |
Mapping of the acromegaly quality of life questionnaire to ED-5D-5L index score among patients with acromegaly
|
Wang, Kailu |
|
|
|
9 |
p. 1381-1391 |
artikel |
68 |
Mapping of the EORTC QLQ-C30 to EQ-5D-5L index in patients with lymphomas
|
Xu, Richard Huan |
|
|
|
9 |
p. 1363-1373 |
artikel |
69 |
Methodological challenges in assessing the impact of comorbidities on costs in Alzheimer’s disease clinical trials
|
Kahle-Wrobleski, Kristin |
|
2014 |
|
9 |
p. 995-1004 |
artikel |
70 |
Modelling the cost-effectiveness of person-centred care for patients with acute coronary syndrome
|
Pirhonen, Laura |
|
|
|
9 |
p. 1317-1327 |
artikel |
71 |
Modest risk-sharing significantly reduces health plans’ incentives for service distortion
|
Brammli-Greenberg, Shuli |
|
|
|
9 |
p. 1359-1374 |
artikel |
72 |
Modifying the quality-adjusted life year calculation to account for meaningful change in health-related quality of life: insights from a pragmatic clinical trial
|
McClure, Nathan S. |
|
|
|
9 |
p. 1441-1451 |
artikel |
73 |
Multiplicative modelling of EQ-5D-3L TTO and VAS values
|
Shafie, Asrul Akmal |
|
|
|
9 |
p. 1411-1420 |
artikel |
74 |
No gain in pain: psychological well-being, participation, and wages in the BHPS
|
Lagomarsino, Elena |
|
|
|
9 |
p. 1375-1389 |
artikel |
75 |
Out-migration and attrition of physicians and dentists before and after EU accession (2003 and 2011): the case of Hungary
|
Varga, Júlia |
|
2016 |
|
9 |
p. 1079-1093 |
artikel |
76 |
Parallel imports and a mandatory substitution reform: a kick or a muff for price competition in pharmaceuticals?
|
Granlund, David |
|
2014 |
|
9 |
p. 969-983 |
artikel |
77 |
Patient hospital choice for hip replacement: empirical evidence from the Netherlands
|
Beukers, Puck D. C. |
|
2013 |
|
9 |
p. 927-936 |
artikel |
78 |
People’s perception and cost-effectiveness of home confinement during an influenza pandemic: evidence from the French case
|
Orset, Caroline |
|
2018 |
|
9 |
p. 1335-1350 |
artikel |
79 |
People’s perception and cost-effectiveness of home confinement during an influenza pandemic: evidence from the French case
|
Orset, Caroline |
|
|
|
9 |
p. 1335-1350 |
artikel |
80 |
Pharmaceutical pricing dynamics in an internal reference pricing system: evidence from changing drugs’ reimbursements
|
Costa, Eduardo |
|
|
|
9 |
p. 1497-1518 |
artikel |
81 |
Population norms in France with EQ-5D-5L: health states, value indexes, and VAS
|
Gautier, Laurène |
|
|
|
9 |
p. 1517-1530 |
artikel |
82 |
Population preferences for non-pharmaceutical interventions to control the SARS-CoV-2 pandemic: trade-offs among public health, individual rights, and economics
|
Mühlbacher, Axel C. |
|
|
|
9 |
p. 1483-1496 |
artikel |
83 |
Potential determinants of deductible uptake in health insurance: How to increase uptake in The Netherlands?
|
Winssen, K. P. M. van |
|
2015 |
|
9 |
p. 1059-1072 |
artikel |
84 |
Preferences for home- and community-based long-term care services in Germany: a discrete choice experiment
|
Lehnert, T. |
|
2018 |
|
9 |
p. 1213-1223 |
artikel |
85 |
Preferences for public involvement in health service decisions: a comparison between best-worst scaling and trio-wise stated preference elicitation techniques
|
Erdem, Seda |
|
2016 |
|
9 |
p. 1107-1123 |
artikel |
86 |
Prescription opioids and economic hardship in France
|
Natali, Ilaria |
|
|
|
9 |
p. 1473-1504 |
artikel |
87 |
Pricing vaccines and drugs in Europe: worth differentiating?
|
Garattini, Livio |
|
|
|
9 |
p. 1345-1348 |
artikel |
88 |
Public preferences for policies promoting a healthy diet: a discrete choice experiment
|
Dieteren, C. M. |
|
|
|
9 |
p. 1429-1440 |
artikel |
89 |
Reassessing the impact of health expenditure on income growth in the face of the global sanitary crisis: the case of developing countries
|
Gaies, Brahim |
|
|
|
9 |
p. 1415-1436 |
artikel |
90 |
Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states
|
Lipman, S. A. |
|
|
|
9 |
p. 1507-1518 |
artikel |
91 |
Should administrative costs in health insurance be included in the risk-equalization? An analysis of five countries
|
Douven, Rudy |
|
|
|
9 |
p. 1437-1453 |
artikel |
92 |
Some adjustments to the human capital and the friction cost methods
|
Targoutzidis, Antonis |
|
2018 |
|
9 |
p. 1225-1228 |
artikel |
93 |
Some economics on personalized and predictive medicine
|
Antoñanzas, F. |
|
2014 |
|
9 |
p. 985-994 |
artikel |
94 |
Stratified medicine in schizophrenia: how accurate would a test of drug response need to be to achieve cost-effective improvements in quality of life?
|
Jin, Huajie |
|
|
|
9 |
p. 1425-1435 |
artikel |
95 |
Tackling the chronic disease burden: are there co-benefits from climate policy measures?
|
Vandenberghe, Désirée |
|
2018 |
|
9 |
p. 1259-1283 |
artikel |
96 |
The attractiveness of jobs in the German care sector: results of a factorial survey
|
Kroczek, Martin |
|
|
|
9 |
p. 1547-1562 |
artikel |
97 |
The cost-effectiveness of transcatheter aortic valve implantation: exploring the Italian National Health System perspective and different patient risk groups
|
Lorenzoni, V. |
|
|
|
9 |
p. 1349-1363 |
artikel |
98 |
The costs and consequences of obesity in Germany: a new approach from a prevalence and life-cycle perspective
|
Effertz, Tobias |
|
2015 |
|
9 |
p. 1141-1158 |
artikel |
99 |
The costs of celiac disease: a contingent valuation in Switzerland
|
Soler, Laia |
|
|
|
9 |
p. 1487-1505 |
artikel |
100 |
The economic impact of multiple sclerosis to the patients and their families in Norway
|
Svendsen, B. |
|
2018 |
|
9 |
p. 1243-1257 |
artikel |
101 |
The effect of economic growth on obesity for the most obese countries: new evidence from the obesity Kuznets curve
|
Aydin, Mucahit |
|
|
|
9 |
p. 1349-1358 |
artikel |
102 |
The effect of informal caregiving on medication: evidence from administrative data
|
Stroka-Wetsch, Magdalena |
|
|
|
9 |
p. 1535-1545 |
artikel |
103 |
The effect of mental and physical health problems on sickness absence
|
Bryan, Mark L. |
|
|
|
9 |
p. 1519-1533 |
artikel |
104 |
The effects of health shocks on family status: do financial incentives encourage marriage?
|
Ehlert, Andree |
|
|
|
9 |
p. 1393-1409 |
artikel |
105 |
The hidden economic burden of air pollution-related morbidity: evidence from the Aphekom project
|
Chanel, Olivier |
|
2015 |
|
9 |
p. 1101-1115 |
artikel |
106 |
The impact of ageing on health care expenditures: a study of steepening
|
Gregersen, Fredrik Alexander |
|
2013 |
|
9 |
p. 979-989 |
artikel |
107 |
The impact of cost-sharing on prescription drug demand: evidence from a double-difference regression kink design
|
Gamba, Simona |
|
|
|
9 |
p. 1591-1599 |
artikel |
108 |
The impact of the diabetes management incentive on diabetes-related services: evidence from Ontario, Canada
|
Thavam, Thaksha |
|
|
|
9 |
p. 1279-1293 |
artikel |
109 |
The impact of tobacco control policies on smoking initiation in eleven European countries
|
Palali, Ali |
|
|
|
9 |
p. 1287-1301 |
artikel |
110 |
The social value of gambling: surplus estimates by gambling types for France
|
Miéra, Maxence |
|
|
|
9 |
p. 1531-1543 |
artikel |
111 |
Timing matters: worker absenteeism in a weekly backward rotating shift model
|
Frick, Bernd |
|
|
|
9 |
p. 1399-1410 |
artikel |
112 |
Validity and responsiveness of the EQ-5D and the KIDSCREEN-10 in children with ADHD
|
Bouwmans, Clazien |
|
2013 |
|
9 |
p. 967-977 |
artikel |
113 |
Values for health states with different life durations
|
Scalone, Luciana |
|
2014 |
|
9 |
p. 917-925 |
artikel |
114 |
Variation in the methodological approach to productivity cost valuation: the case of prostate cancer
|
Hanly, Paul |
|
|
|
9 |
p. 1399-1408 |
artikel |
115 |
Variations in external reference pricing implementation: does it matter for public policy?
|
Gill, Jennifer |
|
|
|
9 |
p. 1375-1397 |
artikel |
116 |
What matters in type 2 diabetes mellitus oral treatment? A discrete choice experiment to evaluate patient preferences
|
Mühlbacher, Axel |
|
2015 |
|
9 |
p. 1125-1140 |
artikel |
117 |
What should we know about the person behind a TTO?
|
Nooten, Floortje van |
|
2018 |
|
9 |
p. 1207-1211 |
artikel |
118 |
Work productivity loss and indirect costs associated with new cardiovascular events in high-risk patients with hyperlipidemia: estimates from population-based register data in Sweden
|
Banefelt, J. |
|
2015 |
|
9 |
p. 1117-1124 |
artikel |